These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27771702)

  • 21. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microcirculation in Acute and Chronic Kidney Diseases.
    Zafrani L; Ince C
    Am J Kidney Dis; 2015 Dec; 66(6):1083-94. PubMed ID: 26231789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    De Boer MP; Meijer RI; Wijnstok NJ; Jonk AM; Houben AJ; Stehouwer CD; Smulders YM; Eringa EC; Serné EH
    Microcirculation; 2012 Jan; 19(1):5-18. PubMed ID: 21883642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and kidney disease.
    Silva Junior GB; Bentes AC; Daher EF; Matos SM
    J Bras Nefrol; 2017 Mar; 39(1):65-69. PubMed ID: 28355395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diets enriched in whey or casein improve energy balance and prevent morbidity and renal damage in salt-loaded and high-fat-fed spontaneously hypertensive stroke-prone rats.
    Singh A; Pezeshki A; Zapata RC; Yee NJ; Knight CG; Tuor UI; Chelikani PK
    J Nutr Biochem; 2016 Nov; 37():47-59. PubMed ID: 27611102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
    Linz D; Hohl M; Schütze J; Mahfoud F; Speer T; Linz B; Hübschle T; Juretschke HP; Dechend R; Geisel J; Rütten H; Böhm M
    Am J Hypertens; 2015 Feb; 28(2):256-65. PubMed ID: 25023205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity-related renal injury in childhood.
    Savino A; Pelliccia P; Chiarelli F; Mohn A
    Horm Res Paediatr; 2010; 73(5):303-11. PubMed ID: 20389099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Kovesdy CP; Furth S; Zoccali C;
    Iran J Kidney Dis; 2017 Mar; 11(2):99-108. PubMed ID: 28270641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Kovesdy CP; Furth SL; Zoccali C;
    Blood Purif; 2017; 43(4):346-354. PubMed ID: 28249281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvasculopathy in ischemic acute kidney injury: consequences and therapeutic implications.
    Patschan D; Patschan S; Müller GA
    Panminerva Med; 2012 Mar; 54(1):45-52. PubMed ID: 22278116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
    Tona F; Serra R; Di Ascenzo L; Osto E; Scarda A; Fabris R; Montisci R; Famoso G; Tellatin S; Foletto M; Giovagnoni A; Iliceto S; Vettor R
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):447-53. PubMed ID: 24548662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obesity and kidney disease - renal consequences of an "epidemic"].
    Schiffl H; Lang SM
    Dtsch Med Wochenschr; 2017 Sep; 142(19):1466-1472. PubMed ID: 28938511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obesity in children and its relationship with chronic kidney disease].
    Zurita-Cruz JN; Villasís-Keever MÁ
    Rev Med Inst Mex Seguro Soc; 2016; 54(4):514-20. PubMed ID: 27197109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney disease in the obese patient.
    Naguib MT
    South Med J; 2014 Aug; 107(8):481-5. PubMed ID: 25084184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
    Reisin E; Jack AV
    Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and CKD progression: hard facts on fat CKD patients.
    Mallamaci F; Tripepi G
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv105-8. PubMed ID: 24179007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?
    Georgianos PI; Sarafidis PA; Liakopoulos V
    Am J Hypertens; 2015 Aug; 28(8):958-65. PubMed ID: 25687879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microcirculation of the septic kidney.
    Zafrani L; Payen D; Azoulay E; Ince C
    Semin Nephrol; 2015 Jan; 35(1):75-84. PubMed ID: 25795501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.